Conversely, TIMP-2 was significantly increased in the serum or cerebrospinal fluid of multiple sclerosis (MS), stroke, Alzheimer’s disease (AD), and Huntington’s disease (HD) patients, suggesting a protective role for TIMP-2 in these diseases [15-17]. Here, TIMP2 is linked to early-onset autosomal dominant Alzheimer disease.